In the liver, the switch in the expression of glucose-sensing enzymes from glucokinase to hexokinase 2 may contribute to inhibition of glycolysis as hexokinase 2, whereas glucokinase is not inhibited by its product G6P; this may limit the availability of glycolytic intermediates despite hyperglycemia. Here, HK2 is linked to Hyperglycemia.